Madrigal Pharmaceuticals (MDGL) announced that Rebecca Taub, M.D., the company’s founder, Chief Medical Officer, and President of Research & Development, will transition to the role of Senior Scientific and Medical Advisor. Dr. Taub will continue to serve on Madrigal’s Board of Directors. Succeeding her, David Soergel, M.D., has been appointed Executive Vice President, Chief Medical Officer, effective April 21, 2025.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MDGL:
- Madrigal Pharmaceuticals management to meet with Oppenheimer
- Madrigal Pharmaceuticals Expands Board with New Appointment
- Madrigal Pharmaceuticals appoints Fouse to its board of directors
- Goldman Sachs Says It’s Time to Pull the Trigger on Healthcare Stocks — Here Are 2 Names to Pounce on Now
- Biotech Alert: Searches spiking for these stocks today